Back to Companies
Alkermes plc.
ALKSNasdaqCIK: 0001520262
Recent Form 4 activity at Alkermes plc. (ALKS) spans 48 filings across 15 insiders (all of them on the sell side). Purchases total $0 against $6.7M in sales — heavily weighted toward selling, for net sales of $6.7M. Hopkinson Craig C. (EVP R&D, Chief Medical Officer) is the most active by dollar volume, and the single largest transaction was $6.0M by Cooke Shane. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$36.4M
Purchases
$0
Sales
$6.7M
Unique Insiders
15
Recent Insider Trades
48 loaded
| Jul 6 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $109.9K |
| Jul 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $463.6K |
| Jun 4 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $87.6K |
| Jun 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $375.0K |
| May 29 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | $687.0K |
| May 22 | ALKS Alkermes plc. | snyderman nancy lynn MD | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | GAYNOR RICHARD | Director | Award | $426.7K |
| May 22 | ALKS Alkermes plc. | Cooke Shane | Director | Exercise | $545.2K |
| May 22 | ALKS Alkermes plc. | Wright Christopher I | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | Cooke Shane | Director | Award | $426.7K |
| May 22 | ALKS Alkermes plc. | GAYNOR RICHARD | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | MCKEON BRIAN P | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | LAURENCIN CATO T | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | Lurker Nancy | Director | Exercise | $481.2K |
| May 22 | ALKS Alkermes plc. | Wilson Frank Anders | Director | Exercise | $481.2K |
| May 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $300.6K |
| Apr 13 | ALKS Alkermes plc. | Lurker Nancy | Director | Exercise | $30.1K |
| Apr 6 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $70.3K |
| Apr 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $319.6K |
| Mar 4 | ALKS Alkermes plc. | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | $180.0K |
| Mar 4 | ALKS Alkermes plc. | Reed Joshua | SVP, Chief Financial Officer | Award | $2.0M |
| Mar 4 | ALKS Alkermes plc. | POPS RICHARD F | Director and CEO, Alkermes plc, Director | Award | $0 |
| Mar 4 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | $201.8K |
| Mar 4 | ALKS Alkermes plc. | Jackson Blair Curtis | EVP, Chief Operating Officer | Award | $2.9M |
| Mar 4 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | $120.1K |
| Mar 4 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $267.5K |
| Feb 27 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Exercise | $24.8K |
| Feb 27 | ALKS Alkermes plc. | Nichols Christian Todd | SVP, Chief Commercial Officer | Exercise | $73.8K |
| Feb 25 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Exercise | $109.9K |
| Feb 25 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Exercise | $21.6K |
| Feb 25 | ALKS Alkermes plc. | Jackson Blair Curtis | EVP, Chief Operating Officer | Exercise | $124.9K |
| Feb 25 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Exercise | $109.9K |
| Feb 25 | ALKS Alkermes plc. | Nichols Christian Todd | SVP, Chief Commercial Officer | Exercise | $91.6K |
| Feb 20 | ALKS Alkermes plc. | Jackson Blair Curtis | EVP, Chief Operating Officer | Exercise | $253.7K |
| Feb 20 | ALKS Alkermes plc. | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Exercise | $53.9K |
| Feb 20 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Exercise | $177.1K |
| Feb 20 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Exercise | $221.2K |
| Feb 2 | ALKS Alkermes plc. | Cooke Shane | Director | Sell | $2.1M |
| Feb 2 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $305.4K |
| Jan 8 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $150.0K |
| Jan 2 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $112.0K |
| Dec 5 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $112.4K |
| Dec 1 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $117.2K |
| Nov 3 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $273.4K |
| Oct 15 | ALKS Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | $283.8K |
| Oct 10 | ALKS Alkermes plc. | Reed Joshua | SVP, Chief Financial Officer | Award | $5.0M |
| Sep 23 | ALKS Alkermes plc. | Reed Joshua | SVP, Chief Financial Officer | Other | $0 |
| Aug 4 | ALKS Alkermes plc. | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Exercise | $23.8K |
48 filings